What's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?
What's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?
Shares of Sharps Technology Inc (NASDAQ:STSS) are trading higher on Friday, with a heavy session volume of 15.17 million.
Sharps Technology股票(NASDAQ:STSS)周五交易价格高涨，成交量达到1517万。
On Wednesday, the medical device and pharmaceutical packaging company received two purchase orders for approximately 1 million SecureGard ultra-low waste smart safety syringes produced at Sharps' manufacturing facility in Hungary.
本周三，这家医疗器械和药品包装公司收到了两份订单，总量约为100万份SecureGard超低浪费智能安全注射器，这些产品是在Sharps在匈牙利的制造工厂生产的。
The first 100k syringe shipment is scheduled for the third week of July, and subsequent deliveries will be made throughout the rest of 2024.
首批10万支注射器将在7月的第三周发货，随后的交货将在2024年其余时间内完成。
The undisclosed customer is a Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies.
未披露客户是一家位于瑞士的化妆品、牙科和眼科注射治疗服务提供商。
The initial 1mL SecureGard syringe orders are a first step in a collaboration that can leverage Sharps' technology, portfolio of drug delivery solutions, and development expertise to support the customer's growing product offerings.
首次成交的SecureGard注射器订单是合作的第一步。此次合作将利用Sharps的技术、药物递送解决方案和开发专业知识为客户不断增长的产品提供支持。
The need for innovative injection solutions continues to grow rapidly as injectables are the first choice for therapies as diverse as vaccines, biologics, weight loss and maintenance, ophthalmic and cosmetic applications, gene therapies, and diabetes and inflammatory disease management.
面对日益增长的需求，适用于疫苗、生物制品、减重和维持、眼科和化妆等疗法的注射器继续迅速增长，而这种创新的注射器解决方案的需求也不断增加。同时，由于关税、召回和来自中国的注射器质量问题的影响，Sharps的高质量智能安全注射器产品的市场需求也在不断增加。
As a result of this market growth and the impact of the tariffs, recalls, and quality issues with Chinese-supplied syringes, Sharps is seeing increasing interest and potential demand for its high-quality smart safety syringe products.
Sharps Technology专门从事药物递送系统的开发和制造。该公司的SecureGard和SoloGard产品系列专注于低浪费和超低浪费注射器技术，采用积极的安全功能和世界卫生组织认可的预防重复使用措施。这些功能能保护一线医务人员免受致命的针刺伤害，并保护公众免受指针的危险。
Also Read: FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns.
FDA针对中国制造的注射器的调查：拜耳迪金森增加美国注射器产量以回应忧虑。
Sharps Technology specializes in the development and manufacturing of drug delivery systems.
Sharps Technology专门从事药物递送系统的开发和制造。
The company's SecureGard and SoloGard product lines focus on low-waste and ultra-low-waste syringe technologies that incorporate active safety features and World Health Organization-accredited re-use prevention measures.
该公司的SecureGard和SoloGard产品系列专注于低浪费和超低浪费注射器技术，采用积极的安全功能和世界卫生组织认可的预防重复使用措施。
These features protect front-line healthcare workers from life-threatening needle stick injuries and protect the public from the dangers of needle re-use.
这些功能能保护一线医务人员免受致命的针刺伤害，并保护公众免受指针的危险。
Sharps has a manufacturing facility in Hungary and is working to close on its recent asset acquisition in South Carolina to expand its manufacturing capacity in the U.S.
Sharps在匈牙利拥有一个制造工厂，并正在努力完成对南卡罗来纳州的资产收购，以扩大其在美国的制造能力。
Price Action: STSS shares are up 8.76% at $0.2520 at last check Friday.
STSS股票价格在周五最后一次检查时上涨8.76%，达到0.2520美元。
Photo via Shutterstock
图片来自shutterstock。
Read Next
阅读下一篇
- Largest Consumer Bank Chase Hints Increased Cost To Consumers For Everyday Banking Services.
- 最大的消费银行JP摩根暗示将提高日常银行服务的消费者成本。